US Patent Issued to TONGHUA DONGBAO PHARMACEUTICAL on July 14 for "Methyl-substituted benzobisoxazole compound and use thereof" (Chinese Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,851, issued on July 14, was assigned to TONGHUA DONGBAO PHARMACEUTICAL Co. LTD. (Jilin, China).

"Methyl-substituted benzobisoxazole compound and use thereof" was invented by Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a new methyl-substituted benzobisoxazole compound and the use thereof in the preparation of drugs for treating related diseases. Specifically disclosed is a compound represented by formula (P) or a pharmaceutically acceptable salt thereof."

The patent was filed on June 10, 2021, under Application No. 18/009,481.

*For further information, including images, charts and tables, please visit: http://p...